ORBIMED ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
OrbiMed Advisors LLC
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
10,865,169 shares
Disclosed Ownership
967,000 shares
Ownership
8.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 18:00:00 UTC
Date of event
30 Jun 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
OrbiMed Advisors LLC 8.9% 967,000 0 967,000 /s/ Carl L. Gordon Carl L. Gordon / Member of OrbiMed Advisors LLC
OrbiMed Capital GP IX LLC 6% 644,667 0 644,667 /s/ Carl L. Gordon Carl L. Gordon / Member